| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Departments of Pediatrics and Medicine, National Jewish Medical and Research Center, Denver, CO 80206;
Institut de Génétique et de Biologie Moléculaire et Cellulaire, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Université Louis Pasteur, C.U. de Strasbourg, Strasbourg, France;
Department of Pathology, Centre Médical Universitaire, Geneva, Switzerland;
§
Basel Institute for Immunology, Basel, Switzerland; and
¶
Departments of Medicine and Immunology, University of Colorado Health Sciences Center, Denver, CO 80262
Unlike parental New Zealand Black (NZB) or New Zealand White (NZW) mice, (NZB x NZW)F1 mice exhibit a lupus-like disease characterized by IgG autoantibody production and severe immune complex-mediated nephritis. In studies of the genetic susceptibility to disease in this F1 model, the NZW MHC (H2z) has been strongly linked with the development of disease, and it was hypothesized that class II MHC genes, particularly Ez genes, may underlie this genetic contribution. In the present study, we bred transgenic B6 mice expressing I-Ez or congenic B6 mice carrying H2z with NZB mice and used a backcross analysis to test the hypothesis that Eaz and/or Ebz genes account for the effect of H2z on disease. The genetic analysis of different backcross combinations showed that unlike mice carrying H2z, mice inheriting Ez transgenes do not demonstrate increased IgG autoantibody production or increased incidence of nephritis. Surprisingly, in the same transgenic backcross mice, inheritance of the endogenous H2b from the B6 strain was strongly linked with the production of IgG autoantibodies, but not with disease. Additional experiments suggested that the level of IgG3 autoantibody production, which is controlled by H2, may be important in the pathogenesis of renal disease. Contributions to autoantibody production were also detected from an NZB locus on distal chromosome 1 (previously named Nba2). Together, these studies provide new insight into the role of MHC in lupus-like autoimmunity.
This article has been cited by other articles:
|
|
 |
|
  Y.-H. Cheung, N.-H. Chang, Y.-C. Cai, G. Bonventi, R. MacLeod, and J. E. Wither Functional Interplay between Intrinsic B and T Cell Defects Leads to Amplification of Autoimmune Disease in New Zealand Black Chromosome 1 Congenic Mice J. Immunol., December 15, 2005; 175(12): 8154 - 8164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Gubbels, T. N. Jorgensen, T. E. Metzger, K. Menze, H. Steele, S. A. Flannery, S. J. Rozzo, and B. L. Kotzin Effects of MHC and Gender on Lupus-Like Autoimmunity in Nba2 Congenic Mice J. Immunol., November 1, 2005; 175(9): 6190 - 6196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Subramanian, Y.-S. Yim, K. Liu, K. Tus, X. J. Zhou, and E. K. Wakeland Epistatic Suppression of Systemic Lupus Erythematosus: Fine Mapping of Sles1 to Less Than 1 Mb J. Immunol., July 15, 2005; 175(2): 1062 - 1072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Wither, G. Lajoie, S. Heinrichs, Y.-C. Cai, N. Chang, A. Ciofani, Y.-H. Cheung, and R. MacLeod Functional Dissection of Lupus Susceptibility Loci on the New Zealand Black Mouse Chromosome 1: Evidence for Independent Genetic Loci Affecting T and B Cell Activation J. Immunol., August 15, 2003; 171(4): 1697 - 1706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. SM. Rahman, S.-K. Tin, P.-N. L. Buenaventura, C.-H. Ho, E. P. H. Yap, R. Y. Y. Yong, and D.-R. Koh A Novel Susceptibility Locus On Chromosome 2 in the (New Zealand Black x New Zealand White)F1 Hybrid Mouse Model of Systemic Lupus Erythematosus J. Immunol., March 15, 2002; 168(6): 3042 - 3049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Xie, S. Chang, P. Yang, C. Jacob, A. Kaliyaperumal, S. K. Datta, and C. Mohan Genetic Contributions of Nonautoimmune SWR Mice Toward Lupus Nephritis J. Immunol., December 15, 2001; 167(12): 7141 - 7149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Paisansinsup, A. N. Vallejo, H. Luthra, and C. S. David HLA-DR Modulates Autoantibody Repertoire, But Not Mortality, in a Humanized Mouse Model of Systemic Lupus Erythematosus J. Immunol., October 1, 2001; 167(7): 4083 - 4090. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Tucker, T. J. Vyse, S. Rozzo, C. L. Roark, S. Izui, and B. L. Kotzin Genetic Control of Glycoprotein 70 Autoantigen Production and Its Influence on Immune Complex Levels and Nephritis in Murine Lupus J. Immunol., August 1, 2000; 165(3): 1665 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Rozzo, T. J. Vyse, K. Menze, S. Izui, and B. L. Kotzin Enhanced Susceptibility to Lupus Contributed from the Nonautoimmune C57BL/10, But Not C57BL/6, Genome J. Immunol., May 15, 2000; 164(10): 5515 - 5521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ibnou-Zekri, M. Iwamoto, M. E. Gershwin, and S. Izui Protection of Murine Lupus by the Ead Transgene Is MHC Haplotype-Dependent J. Immunol., January 1, 2000; 164(1): 505 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Vyse, R. K. Halterman, S. J. Rozzo, S. Izui, and B. L. Kotzin Control of separate pathogenic autoantibody responses marks MHC gene contributions to murine lupus PNAS, July 6, 1999; 96(14): 8098 - 8103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Rozzo, T. J. Vyse, C. S. David, E. Palmer, S. Izui, and B. L. Kotzin Analysis of MHC Class II Genes in the Susceptibility to Lupus in New Zealand Mice J. Immunol., March 1, 1999; 162(5): 2623 - 2630. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
